In contrast, low-affinity interactions, typically requiring micromolar ligand concentrations, often fail to accurately reflect the receptor-ligand dynamics observed within cellular environments
Non-alcohol substance use disorder after bariatric surgery in the prospective, controlled Swedish Obese Subjects study
10.1016/j.metabol.2004.03.007 106
PLoS ONE 10:e0124844 Acknowledgements Open access funding provided by Projekt DEAL
The FDA also categorizes which bulk drug substances compounders may use when creating custom medications, and in late 2023, the agency flagged 19 popular peptides BPC-157, TB-500, and others as Category 2 (an FDA designation for bulk drug substances that present significant safety concerns and may no longer be used in compounding), effectively banning them from traditional compounding
doi:10.1016/j.sjbs.2010.10.004